4'-表阿霉素治疗转移性肾癌的II期研究。
Phase II study of 4'-epi-doxorubicin in metastatic renal cancer.
作者信息
Fosså S D, Wik B, Bae E, Lien H H
出版信息
Cancer Treat Rep. 1982 May;66(5):1219-21.
PMID:6952962
Abstract
In 20 patients with measurable metastatic renal cancer 4'-epi-doxorubicin (Adriamycin) administration (75 mg/m2, every 3 weeks) did not result in any tumor remission. Hematologic and gastrointestinal toxicity was generally mild to moderate. Anthracycline-induced cardiac side effects were not observed in any of the patients.
摘要
在20例可测量的转移性肾癌患者中，给予表柔比星（阿霉素）（75mg/m²，每3周一次）未导致任何肿瘤缓解。血液学和胃肠道毒性一般为轻度至中度。未在任何患者中观察到蒽环类药物引起的心脏副作用。
Zotero 插件